USPTO trademark

SYNT

AllowedUSPTOWord markClass 5

"SYNT" is a word mark owned by Syntis Bio, Inc., filed at the USPTO on June 20, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

Get this data via the API
Official USPTO record
SYNT trademark as filed
As filed with the USPTO
Status
Allowed
Since September 10, 2026
Filed
June 20, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99245099
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns SYNT

The owner and representative on file with the office.

Owner

Syntis Bio, Inc.

Boston, United States

Representative

Sara M. Bauer

Womble Bond and Dickinson LLP

Goods and services

What the mark covers

The products and services SYNT is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of weight gain and obesity; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, and degenerative conditions associated with aging; Pharmaceutical preparations for the treatment and prevention of chronic diseases, conditions, and functional disorders, namely, Alzheimer's Disease, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, metabolic diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Pharmaceutical preparations for the treatment and prevention of chronic metabolic diseases, metabolic conditions, and functional neurological disorders; Biological preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Teas/email correspondence entered

9 earlier steps on the official record.

FAQ

About SYNT

Who owns the trademark "SYNT"?

The USPTO trademark "SYNT" (application 99245099) is owned by Syntis Bio, Inc.

What is the status of "SYNT"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SYNT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ae5-7b09-7598-bb3a-4668fa00c128
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ae5-7b09-7598-bb3a-4668fa00c128",
  "object": "trademark",
  "mark_text": "SYNT",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99245099",
  "filing_date": "2025-06-20",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Syntis Bio, Inc.",
      "entity_id": null
    }
  ]
}